Could 3D software make brain aneurysm surgery safer and cheaper?

NCT ID NCT07433075

Recruiting now Knowledge-focused Sponsor: Sim&Cure Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 3D simulation software called Sim&Size can help doctors plan treatments for unruptured brain aneurysms more accurately than current 2D methods. About 576 adults will be randomly assigned to use the software or standard planning. Researchers will compare hospital costs and complication rates between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Sim&Size software (3D simulation for device placement)
What this could lead to: If successful, this could make aneurysm treatments safer, cheaper, and more precise by helping doctors choose the right implant beforehand.
What could go wrong: This is an early-stage study focused on costs and complications, not a new treatment. The software may not significantly improve outcomes or reduce risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNRUPTURED INTRACRANIAL ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UNRUPTURED INTRACRANIAL ANEURYSM

Contacts and locations

Locations

CHU d'Angers
RECRUITING

Angers, 49100, France
CHU de Bordeaux
RECRUITING

Bordeaux, 33000, France
CHU de Reims
NOT_YET_RECRUITING

Reims, 51092, France
Fondation Rothschild
NOT_YET_RECRUITING

Paris, 75019, France
Hôpital Bicêtre AP-HP
RECRUITING

Le Kremlin-Bicêtre, 94270, France
Hôpital de La Timone
NOT_YET_RECRUITING

Marseille, 13005, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.